China Medical (Germany) Top Insiders
| 2M7C Stock | EUR 1.61 0.13 8.78% |
China Medical employs about 6.1 K people. The company is managed by 11 executives with a total tenure of roughly 65 years, averaging almost 5.0 years of service per executive, having 554.09 employees per reported executive. Examination of China Medical's management performance can provide insight into the company performance.
| Kong Lam Chairman Executive Chairman of the Board, CEO and Presidentident |
| Yanling Chen President CFO, Vice President Executive Director |
China |
China Medical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0558 % which means that it generated a profit of $0.0558 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0991 %, meaning that it generated $0.0991 on every $100 dollars invested by stockholders. China Medical's management efficiency ratios could be used to measure how well China Medical manages its routine affairs as well as how well it operates its assets and liabilities.China Medical holds a total of 2.44 Billion outstanding shares. China Medical System retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as China Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of China Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
China Medical Workforce Comparison
China Medical System is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 11,856. China Medical totals roughly 6,095 in number of employees claiming about 51% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21. China Medical System Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. China Medical System Price Series Summation is a cross summation of China Medical price series and its benchmark/peer.
China Medical Notable Stakeholders
A China Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as China Medical often face trade-offs trying to please all of them. China Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting China Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kong Lam | Executive Chairman of the Board, CEO and Presidentident | Profile | |
| Yanling Chen | CFO, Vice President Executive Director | Profile | |
| Hongbing Chen | COO, Vice President Executive Director | Profile | |
| Liu Yue | Director Relations | Profile | |
| Sanyan Wu | Director Secretary | Profile | |
| Huaizheng MD | Chief Officer | Profile | |
| Lieyi Ma | General Group | Profile | |
| Anjun Huang | Chief Business | Profile | |
| Wai Wong | Chief Technical Officer | Profile | |
| Fei Jiang | Chief China | Profile | |
| James Stearns | Chief America | Profile |
About China Medical Management Performance
The success or failure of an entity such as China Medical System often depends on how effective the management is. China Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of China management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the China management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
China Medical System Holdings Limited, an investment holding company, produces medicines and markets, promotes, and sells drugs in the Peoples Republic of China. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. CHINA M operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3600 people.
China Medical Workforce Analysis
Traditionally, organizations such as China Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare China Medical within its industry.China Medical Manpower Efficiency
Return on China Medical Manpower
| Revenue Per Employee | 1.2M | |
| Revenue Per Executive | 679M | |
| Net Income Per Employee | 265.8K | |
| Net Income Per Executive | 147.3M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 653.5M |
Complementary Tools for China Stock analysis
When running China Medical's price analysis, check to measure China Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medical is operating at the current time. Most of China Medical's value examination focuses on studying past and present price action to predict the probability of China Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medical's price. Additionally, you may evaluate how the addition of China Medical to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |